feed,title,long_url,short_url
BioRxiv,Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides,https://biorxiv.org/cgi/content/short/2023.01.05.522964v1?rss=1,https://da.gd/X2fi
